CME Group Statistics

Total Valuation

CME Group has a market cap or net worth of EUR 87.65 billion. The enterprise value is 89.70 billion.

Market Cap	87.65B
Enterprise Value	89.70B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	360.36M
Shares Outstanding	n/a
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	358.89M

Valuation Ratios

The trailing PE ratio is 26.45 and the forward PE ratio is 24.01.

PE Ratio	26.45
Forward PE	24.01
PS Ratio	15.10
PB Ratio	3.50
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.74, with an EV/FCF ratio of 25.34.

EV / Earnings	27.07
EV / Sales	15.90
EV / EBITDA	20.74
EV / EBIT	22.48
EV / FCF	25.34

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.

Current Ratio	1.02
Quick Ratio	0.02
Debt / Equity	0.14
Debt / EBITDA	0.85
Debt / FCF	0.99
Interest Coverage	25.11

Financial Efficiency

Return on equity (ROE) is 13.39% and return on invested capital (ROIC) is 8.26%.

Return on Equity (ROE)	13.39%
Return on Assets (ROA)	1.76%
Return on Invested Capital (ROIC)	8.26%
Return on Capital Employed (ROCE)	11.22%
Revenue Per Employee	1.54M
Profits Per Employee	881,228
Employee Count	3,760
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	16

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.94

Income Statement

In the last 12 months, CME Group had revenue of EUR 5.80 billion and earned 3.31 billion in profits. Earnings per share was 9.20.

Revenue	5.80B
Gross Profit	5.80B
Operating Income	3.78B
Pretax Income	4.32B
Net Income	3.31B
EBITDA	4.09B
EBIT	3.78B
Earnings Per Share (EPS)	9.20

Full Income Statement

Balance Sheet

The company has 1.41 billion in cash and 3.51 billion in debt, giving a net cash position of -2.11 billion.

Cash & Cash Equivalents	1.41B
Total Debt	3.51B
Net Cash	-2.11B
Net Cash Per Share	n/a
Equity (Book Value)	25.01B
Book Value Per Share	69.54
Working Capital	1.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.62 billion and capital expenditures -81.79 million, giving a free cash flow of 3.54 billion.

Operating Cash Flow	3.62B
Capital Expenditures	-81.79M
Free Cash Flow	3.54B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 65.11% and 57.81%.

Gross Margin	100.00%
Operating Margin	65.11%
Pretax Margin	74.48%
Profit Margin	57.81%
EBITDA Margin	70.43%
EBIT Margin	65.11%
FCF Margin	60.98%

Dividends & Yields

CME Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	105.42%
Buyback Yield	-0.12%
Shareholder Yield	-0.12%
Earnings Yield	3.78%
FCF Yield	4.04%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CME Group has an Altman Z-Score of 0.55. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.55
Piotroski F-Score	n/a